论文部分内容阅读
压宁定（Ｅｂｒａｎｔｉｄ）是一种新型的α１受体阻断剂，主要作用为阻断突触后α１受体，扩张血管，降低外周循环阻力，我们用小剂量压宁定静脉推注，治疗１５例慢性充血性心力衰竭（ＣＨＦ）患者，观察用药前后的血流力学变化，发现血流动力学明显改善。报道如下：１资...
Ebrantid is a new type of α1 receptor blocker. Its main function is to block the post-synaptic α1 receptor, dilate blood vessels and reduce resistance to peripheral circulation. We use low-dose nifedipine to treat Fifteen patients with chronic congestive heart failure (CHF), observed before and after treatment of hemodynamic changes, found that hemodynamics improved significantly. Reported as follows: 1 capital ...